{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:06:55Z","timestamp":1784912815707,"version":"3.55.0"},"reference-count":91,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inflammation is a shared pathogenic pathway underlying multiple chronic conditions and contributes to a loss of healthspan. This study aimed to evaluate the effect of low-dose aspirin on the loss of healthspan in older individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>ASPirin in Reducing Events in the Elderly (ASPREE) was a double-blind, placebo-controlled, randomised trial assessing the effect of daily low-dose aspirin for primary prevention. Community-dwelling participants aged \u226570\u00a0years [or\u2009\u2265\u200965\u00a0years for United States (US) minority ethnic groups] were recruited from Australia and the US. Eligible participants were initially free of major diseases with a life expectancy of more than five years and were randomly assigned to receive 100\u00a0mg of aspirin daily or a placebo. Loss of healthspan was defined as the first occurrence of cardiovascular disease, diabetes, dementia, cancer, or death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 19 114 participants were followed for a median of 4.7\u00a0years, 5835 participants (30.5%) experienced a loss of healthspan. Participants who were older, male, smokers, or had hypertension, or frailty were more likely to experience healthspan loss during the trial. The rate of healthspan loss was 82.1 and 82.7 events per 1000 person-years in the aspirin and placebo groups, respectively. There was no evidence of a substantial difference in the risk of healthspan loss between the aspirin and placebo groups (hazard ratio, 0.98; 95% CI: 0.92\u20131.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Low-dose aspirin had no effect on the rate of loss of healthspan among older community-dwelling adults. Future studies should explore lifestyle and behavioural interventions to extend healthspan.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ageing\/afag218","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:40:08Z","timestamp":1783424408000},"source":"Crossref","is-referenced-by-count":0,"title":["Effect of aspirin on healthspan in community-dwelling older adults: the ASPirin in reducing events in the elderly study"],"prefix":"10.1093","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9125-1882","authenticated-orcid":false,"given":"Haoxin Tina","family":"Zheng","sequence":"first","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University School of Public Health and Preventive Medicine , 503 St Kilda Rd. Melbourne VIC 3004","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8834-4072","authenticated-orcid":false,"given":"Aung Zaw Zaw","family":"Phyo","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University School of Public Health and Preventive Medicine , 503 St Kilda Rd. Melbourne VIC 3004","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimu","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University School of Public Health and Preventive Medicine , 503 St Kilda Rd. Melbourne VIC 3004","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne G","family":"Orchard","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University School of Public Health and Preventive Medicine , 503 St Kilda Rd. Melbourne VIC 3004","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4807-6069","authenticated-orcid":false,"given":"Alice","family":"Owen","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University School of Public Health and Preventive Medicine , 503 St Kilda Rd. Melbourne VIC 3004","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E","family":"Espinoza","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Gerontology and Palliative Medicine, UT Health San Antonio , San Antonio , Texas,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3492-2404","authenticated-orcid":false,"given":"Kerry","family":"Sheets","sequence":"additional","affiliation":[{"name":"Division of Geriatric and Palliative Medicine, Department of Medicine, Hennepin Healthcare , Minneapolis, Minnesota ,","place":["USA"]},{"name":"Berman Center for Outcomes and Clinical Research, Hennepin Healthcare Research Institute , Minneapolis, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1249-6149","authenticated-orcid":false,"given":"Robyn","family":"Woods","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University School of Public Health and Preventive Medicine , 503 St Kilda Rd. Melbourne VIC 3004","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7039-6325","authenticated-orcid":false,"given":"Joanne","family":"Ryan","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University School of Public Health and Preventive Medicine , 503 St Kilda Rd. Melbourne VIC 3004","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"2026072412312383700_ref1","volume-title":"Ageing and Health [Internet]","author":"WHO","year":"2024"},{"key":"2026072412312383700_ref2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S2213-8587(23)00327-3","article-title":"Daily low-dose aspirin and incident type 2 diabetes in community-dwelling healthy older adults: a post-hoc analysis of efficacy and safety in the ASPREE randomised placebo-controlled trial","volume":"12","author":"Zoungas","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072412312383700_ref3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41536-021-00169-5","article-title":"Longevity leap: mind the healthspan gap","volume":"6","author":"Garmany","year":"2021","journal-title":"npj Regener Med"},{"key":"2026072412312383700_ref4","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1017\/jns.2020.26","article-title":"From lifespan to healthspan: the role of nutrition in healthy ageing","volume":"9","author":"Wickramasinghe","year":"2020","journal-title":"J Nutr Sci"},{"key":"2026072412312383700_ref5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11357-018-0036-9","article-title":"How healthy is the healthspan concept?","volume":"40","author":"Kaeberlein","year":"2018","journal-title":"Geroscience."},{"key":"2026072412312383700_ref6","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1113\/jphysiol.2014.282665","article-title":"Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity","volume":"594","author":"Seals","year":"2016","journal-title":"J Physiol"},{"key":"2026072412312383700_ref7","volume-title":"Disability","author":"WHO","year":"2023"},{"key":"2026072412312383700_ref8","doi-asserted-by":"crossref","first-page":"1071656","DOI":"10.3389\/fpsyg.2023.1071656","article-title":"Well-being and quality of life in people with disabilities practicing sports, athletes with disabilities, and para-athletes: insights from a critical review of the literature","volume":"14","author":"Puce","year":"2023","journal-title":"Front Psychol"},{"key":"2026072412312383700_ref9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/gerona\/glr223","article-title":"Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span","volume":"67A","author":"Andersen","year":"2012","journal-title":"The Journals of Gerontology: Series A"},{"key":"2026072412312383700_ref10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann Afr Med"},{"key":"2026072412312383700_ref11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur Cardiol"},{"key":"2026072412312383700_ref12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"2026072412312383700_ref13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020616","article-title":"Neuroinflammation: a potential risk for dementia","volume":"23","author":"Ahmad","journal-title":"Int J Mol Sci"},{"key":"2026072412312383700_ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112906","article-title":"The role of inflammation in cardiovascular disease","volume":"23","author":"Henein","journal-title":"Int J Mol Sci."},{"key":"2026072412312383700_ref15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2026072412312383700_ref16","doi-asserted-by":"publisher","DOI":"10.3390\/cells13221906","article-title":"Inflammation: the cause of all diseases","volume":"13","author":"Chavda","journal-title":"Cells."},{"key":"2026072412312383700_ref17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jnci\/djad231","article-title":"Long-term aspirin use and cancer risk: a 20-year cohort study","volume":"116","author":"Skriver","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"2026072412312383700_ref18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.annepidem.2023.06.002","article-title":"Low-dose acetylsalicylic acid for cancer prevention considering risk factors: a retrospective cohort study","volume":"84","author":"Florensa","year":"2023","journal-title":"Ann Epidemiol"},{"key":"2026072412312383700_ref19","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat Med"},{"key":"2026072412312383700_ref20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: an expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell."},{"key":"2026072412312383700_ref21","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet."},{"key":"2026072412312383700_ref22","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jama.2022.5207","article-title":"Aspirin use to prevent cardiovascular disease: US preventive services task force recommendation statement","volume":"327","author":"Davidson","year":"2022","journal-title":"Jama."},{"key":"2026072412312383700_ref23","doi-asserted-by":"crossref","first-page":"220124","DOI":"10.1098\/rsob.220124","article-title":"Aspirin and cancer: biological mechanisms and clinical outcomes","volume":"12","author":"Elwood","year":"2022","journal-title":"Open Biol"},{"key":"2026072412312383700_ref24","first-page":"100884","article-title":"Role of aspirin in cancer prevention","volume":"43","author":"Sun","year":"2025","journal-title":"Cancer Treat Res Commun"},{"key":"2026072412312383700_ref25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet."},{"key":"2026072412312383700_ref26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin","volume":"110","author":"Vane","year":"2003","journal-title":"Thromb Res"},{"key":"2026072412312383700_ref27","doi-asserted-by":"crossref","first-page":"578071","DOI":"10.3389\/fnagi.2020.578071","article-title":"Aspirin use on incident dementia and mild cognitive decline: a systematic review and meta-analysis","volume":"12","author":"Li","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"2026072412312383700_ref28","doi-asserted-by":"crossref","first-page":"1099810","DOI":"10.3389\/fphar.2023.1099810","article-title":"Low- or high-dose preventive aspirin use and risk of death from all-cause, cardiovascular disease, and cancer: a nationally representative cohort study","volume":"14","author":"Chen","year":"2023","journal-title":"Front Pharmacol"},{"key":"2026072412312383700_ref29","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"2026072412312383700_ref30","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"The Lancet"},{"key":"2026072412312383700_ref31","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of aspirin for primary prevention in persons with diabetes mellitus","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"key":"2026072412312383700_ref32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/jnci\/djaa114","article-title":"Effect of aspirin on cancer incidence and mortality in older adults","volume":"113","author":"McNeil","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"2026072412312383700_ref33","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJMoa2504650","article-title":"Low-dose aspirin for PI3K-altered localized colorectal cancer","volume":"393","author":"Martling","year":"2025","journal-title":"N Eng J Med."},{"key":"2026072412312383700_ref34","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1212\/WNL.0000000000009277","article-title":"Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline","volume":"95","author":"Ryan","year":"2020","journal-title":"Neurology."},{"key":"2026072412312383700_ref35","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/ehac179","article-title":"Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial","volume":"43","author":"Parish","year":"2022","journal-title":"Eur Heart J"},{"key":"2026072412312383700_ref36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/dc08-1206","article-title":"A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women","volume":"32","author":"Pradhan","year":"2009","journal-title":"Diabetes Care"},{"key":"2026072412312383700_ref37","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.amjmed.2008.09.044","article-title":"Aspirin use and risk of type 2 diabetes in apparently healthy men","volume":"122","author":"Hayashino","year":"2009","journal-title":"Am J Med"},{"key":"2026072412312383700_ref38","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","article-title":"Effect of aspirin on all-cause mortality in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"2026072412312383700_ref39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.amjmed.2011.01.018","article-title":"Effect of aspirin on mortality in the primary prevention of cardiovascular disease","volume":"124","author":"Raju","year":"2011","journal-title":"Am J Med"},{"key":"2026072412312383700_ref40","doi-asserted-by":"crossref","first-page":"e030034","DOI":"10.1136\/bmjopen-2019-030034","article-title":"All-cause mortality following low-dose aspirin treatment for patients with high cardiovascular risk in remote Australian aboriginal communities: an observational study","volume":"10","author":"Zhao","year":"2020","journal-title":"BMJ Open"},{"key":"2026072412312383700_ref41","volume-title":"Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication [Internet]. Rockville (MD): U.S. Preventive Services Task Force;","author":"USPSTK","year":"2022"},{"key":"2026072412312383700_ref42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s42003-019-0290-0","article-title":"Identification of 12 genetic loci associated with human healthspan","volume":"2","author":"Zenin","year":"2019","journal-title":"Commun Biol"},{"key":"2026072412312383700_ref43","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cct.2013.09.014","article-title":"Study design of ASPirin in reducing events in the elderly (ASPREE): a randomized, controlled trial","volume":"36","author":"Group AI","year":"2013","journal-title":"Contemp Clin Trials"},{"key":"2026072412312383700_ref44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1747493017741383","article-title":"The aspirin in reducing events in the elderly trial: statistical analysis plan","volume":"13","author":"Wolfe","year":"2018","journal-title":"Int J Stroke"},{"key":"2026072412312383700_ref45","article-title":"Definitions of healthspan: a systematic review","volume":"111","author":"Masfiah","journal-title":"Ageing Res Rev"},{"key":"2026072412312383700_ref46","doi-asserted-by":"crossref","first-page":"e53449","DOI":"10.7554\/eLife.53449","article-title":"Germline burden of rare damaging variants negatively affects human healthspan and lifespan","volume":"9","author":"Shindyapina","year":"2020","journal-title":"eLife."},{"key":"2026072412312383700_ref47","doi-asserted-by":"crossref","first-page":"103318","DOI":"10.1016\/j.ebiom.2021.103318","article-title":"Clinical biomarkers and associations with healthspan and lifespan: evidence from observational and genetic data","volume":"66","author":"Li","year":"2021","journal-title":"EBioMedicine."},{"key":"2026072412312383700_ref48","doi-asserted-by":"crossref","first-page":"663449","DOI":"10.3389\/fgene.2021.663449","article-title":"Associations between sleep quality and health span: a prospective cohort study based on 328,850 UK biobank participants","volume":"12","author":"Sambou","year":"2021","journal-title":"Front Genet"},{"key":"2026072412312383700_ref49","doi-asserted-by":"crossref","first-page":"15929","DOI":"10.1038\/s41598-021-95425-5","article-title":"Biological age in healthy elderly predicts aging-related diseases including dementia","volume":"11","author":"Wu","year":"2021","journal-title":"Sci Rep"},{"key":"2026072412312383700_ref50","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/gerona\/glaa316","article-title":"Effect of aspirin on activities of daily living disability in community-dwelling older adults","volume":"76","author":"Woods","year":"2021","journal-title":"J Gerontol Series A"},{"key":"2026072412312383700_ref51","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1532-5415.1983.tb03391.x","article-title":"Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living","volume":"31","author":"Katz","year":"1983","journal-title":"J Am Geriatr Soc"},{"key":"2026072412312383700_ref52","article-title":"Key Signaling pathways in aging and potential interventions for healthy aging","volume":"10","author":"Yu","journal-title":"Cells."},{"key":"2026072412312383700_ref53","doi-asserted-by":"crossref","first-page":"R741","DOI":"10.1016\/j.cub.2012.07.024","article-title":"Ageing as a risk factor for disease","volume":"22","author":"Niccoli","year":"2012","journal-title":"Curr Biol"},{"key":"2026072412312383700_ref54","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.4049\/jimmunol.0900477","article-title":"Effects of low-dose aspirin on acute inflammatory responses in Humans1","volume":"183","author":"Morris","year":"2009","journal-title":"J Immunol"},{"key":"2026072412312383700_ref55","doi-asserted-by":"crossref","first-page":"1507683","DOI":"10.3389\/fnagi.2024.1507683","article-title":"Aspirin modulates inflammatory biomarkers in patients with subcortical silent brain infarcts","volume":"16","author":"Sung","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"2026072412312383700_ref56","doi-asserted-by":"crossref","first-page":"S704","DOI":"10.1016\/j.ajog.2020.12.1166","article-title":"1142 low dose aspirin influence on biomarkers of endothelial disruption and inflammation","volume":"224","author":"Srinivasan","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"2026072412312383700_ref57","first-page":"e60659","article-title":"Effects of low and high doses of aspirin on inflammatory markers in diabesity patients: a quasi-experimental study","volume":"16","author":"Singh","year":"2024","journal-title":"Cureus."},{"key":"2026072412312383700_ref58","doi-asserted-by":"crossref","first-page":"100764","DOI":"10.1016\/j.lanhl.2025.100764","article-title":"Aspirin and healthy lifespan in older people: main outcome of the ASPREE-XT observational study","volume":"6","author":"Shah","year":"2025","journal-title":"Lancet Healthy Longev"},{"key":"2026072412312383700_ref59","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","article-title":"Effect of aspirin on disability-free survival in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"2026072412312383700_ref60","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/geront\/gnv130","article-title":"Lifespan and Healthspan: past, present, and promise","volume":"55","author":"Crimmins","year":"2015","journal-title":"Gerontologist."},{"key":"2026072412312383700_ref61","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing\u2014when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"2026072412312383700_ref62","article-title":"Effect of aspirin on grip strength and gait speed in community-dwelling older adults in the ASPirin in reducing events in the elderly (ASPREE) study","volume":"80","author":"Phyo","journal-title":"J Gerontol A."},{"key":"2026072412312383700_ref63","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.2337\/dc13-2505","article-title":"Prevalence of metabolic syndrome among Hispanics\/Latinos of diverse background: the Hispanic community health study\/study of Latinos","volume":"37","author":"Heiss","year":"2014","journal-title":"Diabetes Care"},{"key":"2026072412312383700_ref64","first-page":"575","article-title":"Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms","volume":"34","author":"Petrie","year":"2018","journal-title":"Can J Cardiol"},{"key":"2026072412312383700_ref65","volume-title":"Health Conditions Prevalence","author":"Australian Bureau of Statistics","year":"2022"},{"key":"2026072412312383700_ref66","volume-title":"Cardiovascular Diseases (CVDs)","author":"WHO","year":"2025"},{"key":"2026072412312383700_ref67","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.amepre.2013.10.029","article-title":"Age and cancer risk: a potentially modifiable relationship","volume":"46","author":"White","year":"2014","journal-title":"Am J Prev Med"},{"key":"2026072412312383700_ref68","doi-asserted-by":"crossref","first-page":"e2450241","DOI":"10.1001\/jamanetworkopen.2024.50241","article-title":"Global Healthspan-lifespan gaps among 183 World Health Organization member states","volume":"7","author":"Garmany","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026072412312383700_ref69","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s11154-022-09737-6","article-title":"Mortality and morbidity in ageing men: biology, lifestyle and environment","volume":"23","author":"Zhao","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"key":"2026072412312383700_ref70","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fmed.2019.00218","article-title":"Health and well-being in late life: gender differences worldwide","volume":"6","author":"Carmel","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"2026072412312383700_ref71","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2307\/2136961","article-title":"The twain meet: empirical explanations of sex differences in health and mortality","volume":"30","author":"Verbrugge","year":"1989","journal-title":"J Health Soc Behav"},{"key":"2026072412312383700_ref72","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1016\/S2468-2667(24)00053-7","article-title":"Differences across the lifespan between females and males in the top 20 causes of disease burden globally: a systematic analysis of the global burden of disease study 2021","volume":"9","author":"Patwardhan","year":"2024","journal-title":"Lancet Public Health"},{"key":"2026072412312383700_ref73","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1080\/08870446.2017.1325890","article-title":"Tobacco smoking: health impact, prevalence, correlates and interventions","volume":"32","author":"West","year":"2017","journal-title":"Psychol Health"},{"key":"2026072412312383700_ref74","volume-title":"Obesity and Overweight","author":"WHO","year":"2025"},{"key":"2026072412312383700_ref75","doi-asserted-by":"crossref","first-page":"107786","DOI":"10.1016\/j.maturitas.2023.107786","article-title":"Polygenic risk for termination of the \u2018healthspan\u2019 and its interactions with lifestyle factors: a prospective cohort study based on 288,359 participants","volume":"175","author":"Liang","year":"2023","journal-title":"Maturitas."},{"key":"2026072412312383700_ref76","doi-asserted-by":"crossref","first-page":"80","DOI":"10.21037\/gs.2019.12.03","article-title":"Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery","volume":"9","author":"Shariq","year":"2020","journal-title":"Gland Surg"},{"key":"2026072412312383700_ref77","article-title":"Obesity and cancer: a current overview of epidemiology, pathogenesis","volume":"15","author":"Pati","journal-title":"Outcomes, and Management Cancers (Basel)"},{"key":"2026072412312383700_ref78","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.phrs.2017.11.003","article-title":"Hypertension and cardiovascular risk: general aspects","volume":"129","author":"Kjeldsen","year":"2018","journal-title":"Pharmacol Res"},{"key":"2026072412312383700_ref79","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","article-title":"High blood pressure and cardiovascular disease","volume":"75","author":"Fuchs","year":"2020","journal-title":"Hypertension."},{"key":"2026072412312383700_ref80","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/mpr.20","article-title":"The effect of misclassification on the estimation of association: a review","volume":"14","author":"H\u00f6fler","year":"2005","journal-title":"Int J Methods Psychiatr Res"},{"key":"2026072412312383700_ref81","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/1471-0528.15199","article-title":"Randomised controlled trials - the gold standard for effectiveness research: study design: randomised controlled trials","volume":"125","author":"Hariton","year":"2018","journal-title":"Bjog."},{"key":"2026072412312383700_ref82","doi-asserted-by":"crossref","first-page":"107231","DOI":"10.1016\/j.cct.2023.107231","article-title":"Health characteristics and aspirin use in participants at the baseline of the ASPirin in reducing events in the elderly - eXTension (ASPREE-XT) observational study","volume":"130","author":"Ernst","year":"2023","journal-title":"Contemp Clin Trials"},{"key":"2026072412312383700_ref83","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/COPD.S5237","article-title":"Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III follow-up study","volume":"4","author":"Shavelle","year":"2009","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026072412312383700_ref84","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.rmed.2018.02.015","article-title":"Long term survival after admission for COPD exacerbation: a comparison with the general population","volume":"137","author":"Hirtum","year":"2018","journal-title":"Respir Med"},{"key":"2026072412312383700_ref85","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ije\/dyy279","article-title":"Cohort profile: the ASPREE longitudinal study of older persons (ALSOP)","volume":"48","author":"McNeil","year":"2019","journal-title":"Int J Epidemiol"},{"key":"2026072412312383700_ref86","volume-title":"Hypertension and High Measured Blood Pressure","author":"Australian Bureau of Statistics","year":"2022"},{"key":"2026072412312383700_ref87","volume-title":"Overweight and Obesity","author":"Australian Institute of Health and Welfare.","year":"2024"},{"key":"2026072412312383700_ref88","volume-title":"Diabetes: Australian Facts","author":"Australian Institute of Health and Welfare.","year":"2024"},{"key":"2026072412312383700_ref89","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/ije\/dym184","article-title":"Cohort profile: the 45 and up study","volume":"37","author":"Banks","year":"2008","journal-title":"Int J Epidemiol"},{"key":"2026072412312383700_ref90","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1017\/S1041610210001067","article-title":"The Sydney memory and ageing study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70\u201390 years","volume":"22","author":"the M","year":"2010","journal-title":"Int Psychogeriatr"},{"key":"2026072412312383700_ref91","doi-asserted-by":"crossref","first-page":"718","DOI":"10.18632\/aging.100694","article-title":"Translational geroscience: emphasizing function to achieve optimal longevity","volume":"6","author":"Seals","year":"2014","journal-title":"Aging (Albany NY)"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/55\/7\/afag218\/69956860\/afag218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/55\/7\/afag218\/69956860\/afag218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:31:38Z","timestamp":1784910698000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afag218\/8741511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":91,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afag218","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7]]},"article-number":"afag218"}}